# Vicinitas Therapeutics: Research, South San Francisco, United States

> Vicinitas Therapeutics: Vicinitas Therapeutics is a biotechnology company founded in 2022 and based in South San Francisco, California.

Source: https://millionrounds.com/startup/vicinitas-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# Vicinitas Therapeutics

Vicinitas Therapeutics is a biotechnology company founded in 2022 and based in South San Francisco, California.

Funding reported Last round: Series A

Research South San Francisco, United States

Company summary

- **Founded:** 2022 4 years old
- **Team:** 3 1 to 10 people
- **Funding reported:** $65M in dollars
- **Last round:** Series A Jul 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Vicinitas Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Vicinitas Therapeutics

Vicinitas Therapeutics is a biotechnology company founded in 2022 and based in South San Francisco, California.

It was established through a collaboration between the University of California, Berkeley, and the Novartis Institutes for BioMedical Research. The company focuses on developing innovative therapeutic solutions for challenging targets known as "undruggable" proteins, particularly in the fields of oncology and monogenic disorders. The core of Vicinitas' work is its proprietary DUBTAC platform, which enables the stabilization of proteins that are often degraded by the cell's ubiquitin-proteasome system. This technology aims to restore the function of essential proteins, offering potential treatments for diseases such as cancer, cystic fibrosis, and Stargardt disease. Vicinitas has successfully raised $65 million in funding, positioning itself for impactful advancements in drug discovery and development.

## What company datasets say Vicinitas Therapeutics raised

Funding, as reported

Reported in all **$65M** in dollars

Rounds **1**

Last round **Series A**

Last round size **$65M**

Last round date **Jul 2022**

Investors listed **6**

## The company, in detail

What they build

Known for

protein stability drugs health care protein degradation inhibitors protein rescue biotechnology research protein stabilization in cancer protein stabilization cancer therapy protein stabilization in genetic diseases therapeutic proteins genetic disorders small molecule drugs targeted protein rescue targeted therapy biopharma protein homeostasis

Built with from their website

Google Tag Manager HRMDirect Mobile Friendly Bootstrap Amazon AWS reCAPTCHA Adobe Fonts

- **Sector:** Research
- **Industry code:** NAICS 54171, SIC 2834
- **Region:** California
- **Revenue:** $1.4M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/vicinitas-therapeutics)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put Vicinitas Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)